| Identification | |
|---|---|
| Name | Felypressin |
| Accession Number | DB00093 (BIOD00114, BTD00114) |
| Type | biotech |
| Description | Synthetic analog of lypressin with more vasoconstrictor than antidiuretic action. It is used as a hemostatic. |
| Structure |
|
| Categories (*) | |
| Molecular Weight | 1040.2190 |
| Groups | approved |
| Monoisotopic Weight | Not Available |
| Pharmacology | |
| Indication | For use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential. |
| Mechanism of action | Felypressin binds to the vasopressin receptor V1a. This causes contraction of the smooth muscle in the vascular bed, especially capillaries, small arterioles and venules. |
| Absorption | Not Available |
| Protein binding | Not Available |
| Biotransformation | Not Available |
| Route of elimination | Not Available |
| Toxicity | Not Available |
| Affected organisms |
|
| Interactions | |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
| Vasopressin V1a receptor | |
|---|---|
| Name | Vasopressin V1a receptor |
| Gene Name | AVPR1A |
| Pharmacological action | yes |
| Actions | agonist |
| References |
|
| DTHybrid score | 0.7353 |
| Id | Partner name | Gene Name | Score |
|---|---|---|---|
| 322 | Vasopressin V2 receptor | AVPR2 | 0.366 |
| 850 | Vasopressin V1b receptor | AVPR1B | 0.2393 |
| 4512 | Cytochrome P450 3A4 | CYP3A4 | 0.052 |
| 1735 | Canalicular multispecific organic anion transporter 1 | ABCC2 | 0.0327 |
| 290 | Prostaglandin G/H synthase 2 | PTGS2 | 0.0271 |
| 20 | Prostaglandin G/H synthase 1 | PTGS1 | 0.0254 |
| 1588 | Multidrug resistance protein 1 | ABCB1 | 0.0253 |